A company still losing money with shrinking sales.
Going well
Buying back shares: share count down 8.6% in 3 years
Watch out for
Losing money
High debt: 5.95x equity
Money moves
No insider buying or selling in the last 30 days
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$10.59-1.9% that day
Company value
$1.4B
Share price times all shares
Price vs sales
4.8x
No profit over the last year, so this compares value with sales instead
Cash vs value
15%
Cash as a share of company value
Debt vs value
26%
Debt as a share of company value
From SKIN's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$72.1M-7.8% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $290.0M, down 6.5% from the 12 months before. Over 5 years, sales grew about 20% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of SKIN. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$213M
Profit in 5 years$21M
Price these guesses point to$2.86-73% vs $10.59 todayAbout -23% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 22% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.